{"nct_id":"NCT01639248","title":"Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC","status":"COMPLETED","status_verified_date":"2017-06","start_date":"2012-07","start_date_type":null,"primary_completion_date":"2017-06","primary_completion_date_type":"ACTUAL","completion_date":"2017-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CASI"]}